Biodistribution of canine leucocytes labelled with technetium-99m stannous fluoride colloid in whole blood and their ability to localise to sites of induced inflammation

Veterinary Journal

Volumn 185, Issue 2, 2010, Pages 157-162

  Abushhiwa, Mohamed H ^a   Salehi, Nouria S ^b   Lichtenstein, Meir ^b   Lording, Peter M ^a   Finnin, Peter J ^a   Whitton, Robert C ^a   Charles, Jennifer A ^a   Parry, Bruce W ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Biodistribution; Canine leucocytes; Inflammation; Technetium 99m stannous fluoride colloid; Tumour necrosis factor

Indexed keywords

RADIOPHARMACEUTICAL AGENT; TECHNETIUM STANNOUS FLUORIDE COLLOID TC 99M; TECHNETIUM TIN COLLOID TC 99M; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; TECHNETIUM DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CELL LABELING; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOG; HISTOPATHOLOGY; IN VIVO STUDY; INCUBATION TIME; INFLAMMATION; INFLAMMATORY INFILTRATE; LEUKOCYTE; NONHUMAN; ROOM TEMPERATURE; SCINTILLATION CAMERA; TISSUE DISTRIBUTION; VENOUS BLOOD; ANIMAL; CHEMISTRY; DIAGNOSTIC USE; DOG DISEASES; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; SCINTISCANNING; VETERINARY;

ANIMALS; DOG DISEASES; DOGS; FEMALE; INFLAMMATION; INJECTIONS, INTRAVENOUS; LEUKOCYTES; MALE; TECHNETIUM COMPOUNDS; TISSUE DISTRIBUTION; TUMOR NECROSIS FACTOR-ALPHA;

CANIS FAMILIARIS;

EID: 77954032142     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2009.05.023     Document Type: Article

References (32)

1. Abushhiwa M., Salehi N., Slocombe R., Finnin P., Caple I., Lording P., Whitton R., Clarke A. Tc-99m stannous fluoride colloid: efficiency of labeling equine and canine leucocytes and effect on cell viability. ANZ Nuclear Medicine 2006, 37:1-3.
2. 99mTc stannous colloid. Nuclear Medicine and Biology 2008, 35:707-712.
3. Becker W., Bair J., Behr T., Repp R., Steckenbach H., Beck H., Gramatzki M., Winship M.J., Goldenberg D.M., Wolf F. Detection of soft-tissue infection and osteomyelitis using a technetium-99m-labeled anti-granulocyte monoclonal antibody fragment. Journal of Nuclear Medicine 1994, 35:1436-1443.
4. Becker W., Palestro C.J., Winship J., Feld T., Pinsky C.M., Wolf F., Goldenberg D.M. Rapid imaging of infection with a monoclonal antibody fragment (Leukoscan). Clinical Orthopaedics and Related Research 1996, 329:263-272.
5. 99mTc-labeled interleukin 8 for the scintigraphic detection of infection and inflammation: first clinical evaluation. Journal of Nuclear Medicine 2007, 48:337-343.
6. Boyd S.J., Nour R., Quinn R.J., McKay E., Butler S.P. Evaluation of white cell scintigraphy using indium-111 and technetium-99m labeled leukocytes. European Journal of Nuclear Medicine and Molecular Imaging 1993, 20:201-206.
7. 99mTc stannous fluoride colloid labeled leukocytes. Nuclear Medicine Communications 2002, 23:153-160.
8. Chianelli M., Mather S.J., Martin-Comin J., Signore A. Radiopharmaceuticals for the study of inflammatory processes: a review. Nuclear Medicine Communications 1997, 18:437-455.
9. 99mTc-stannous colloid-labeled leucocyte scintigraphy in the evaluation of the painful arthroplasty. Clinical Nuclear Medicine 1996, 21:838-843.
10. Fischman A.J., Pike M.C., Kroon D., Fucello A.J., Rexinger D., Kate C., Wilkinson R., Rubin R.H., Strauss H.W. Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs. Journal of Nuclear Medicine 1991, 32:483-491.
11. Gallagher H., Ramsay S.C., Barnes J., Magges J., Cassidy N., Ketheesan N. Neutrophil labeling with [99mTc]-technetium stannous colloid is complement receptor 3-mediated and increases the neutrophil priming response to lipopolysaccharide. Nuclear Medicine and Biology 2006, 33:433-439.
12. Gibson P., Lichtenstein M., Salehi N., Hebbard G., Andrews J. Value of positive technetium-99m leucocyte scans in predicting intestinal inflammation. Gut 1991, 32:1502-1507.
13. 99mTc-stannous colloid in whole blood. European Journal of Nuclear Medicine and Molecular Imaging 1984, 9:216-219.
14. Hanna R.W., Lomas F. Identification of factors affecting technetium-99m leucocyte labeling by phagocytic engulfment and development of an optimal technique. European Journal of Nuclear Medicine and Molecular Imaging 1986, 12:159-162.
15. 2 colloid kit for leucocyte labeling. Journal of Nuclear Medicine 1989, 30:1257-1263.
16. Hoskinson J.J., Gregory B.D., Clark S.P. Indium-111-chloride-leukocytes and three phase bone scintigraphy: a comparison for imaging experimental osteomyelitis. Journal of Nuclear Medicine 1991, 32:67-75.
17. Kelbaek H., Fogh J. Technetium-99m labeling of polymorphonuclear leukocytes: preparation with two different stannous agents. Journal of Nuclear Medicine 1985, 26:68-71.
18. McAfee J.G., Gagne G., Subramanian G., Grossman Z.D., Thomas F.D., Roskopf M.L., Fernandes P., Lyons B.J. Distribution of leukocytes labeled with In-111 oxine in dogs with acute inflammatory lesions. Journal of Nuclear Medicine 1980, 21:1059-1068.
19. 111In oxine in dogs. European Journal of Nuclear Medicine and Molecular Imaging 1987, 13:353-357.
20. McAfee J.G., Gagne G., Subramanian G., Schneider R.F. The localization of indium-111-leukocytes, gallium-67-polyclonal IgG and other radioactive agents in acute focal inflammatory lesions. Journal of Nuclear Medicine 1991, 32:2126-2131.
21. Mock B.H., English D. Leukocyte labeling with technetium-99m tin colloids. Journal of Nuclear Medicine 1987, 28:1471-1477.
22. Mock B.H., Schauwecker D.S., English D., Young K.A., Wellman H.N. In vivo kinetics of canine leukocytes labelled with technetium-99m HM-PAO and indium-111 tropolonate. Journal of Nuclear Medicine 1988, 29:1246-1251.
23. Moyer B.R., Vallabhajosula S., Lister-James J., Bush L.R., Cyr J.E., Snow D.A., Bastidas D., Lipszyc H., Dean R.T. Technetium-99m-white blood cell-specific imaging agent developed from platelet factor 4 to detect infection. Journal of Nuclear Medicine 1996, 37:673-679.
24. 99mTc-stannous colloid white cell scintigraphy in childhood inflammatory bowel disease. Journal of Nuclear Medicine 2004, 45:261-265.
25. Pullman W.E., Sullivan P.J., Barratt P.J., Lising J., Booth J.A., Doe W.F. Assessment of inflammatory bowel disease activity by technetium 99m phagocyte scanning. Gastroenterology 1988, 95:989-996.
26. Puncher M.P., Blower P.J. Labeling of leucocytes with colloid technetium-99m-SnF2: an investigation of the labeling process by autoradiography. European Journal of Nuclear Medicine and Molecular Imaging 1995, 22:101-107.
27. 99mTc stannous colloid white cell scanning. Nuclear Medicine Communications 2001, 22:1193-1199.
28. Tremblay C., Pardis M., Dore M. Expression of E- and P-selectin in tumor necrosis factor-induced dermatitis in dogs. Veterinary Pathology 2001, 38:261-268.
29. 99mTc-tin fluoride colloid-labelled-leucocytes. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2005, 49:319-324.
30. Uchida T., Vincent P.C. In vitro studies of leukocyte labeling with technetium-99m. Journal of Nuclear Medicine 1976, 17:313-316.
31. Van der Laken C.J., Boerman O.C., Oyen W.J.G., Van de Ven M.T.P., Claessens R.A.M.J., Van der Meer J.W.M., Corstens F.H.M. Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model. European Journal of Nuclear Medicine and Molecular Imaging 1995, 22:1249-1255.
32. Van der Laken C.J., Boerman O.C., Oyen W.J.G., Van de Ven M.T.P., Vander Meer J.W.M., Corstens F.H.M. Scintigraphic detection of infection and inflammation: new developments with special emphasis on receptor interaction. European Journal of Nuclear Medicine and Molecular Imaging 1998, 25:535-546.